Canadian Imperial Bank of Commerce
CM
The Toronto-Dominion Bank
TD
Bank of Montreal
BMO
Bank of Nova Scotia
BNS
Royal Bank of Canada
RY
CA Stock MarketDetailed Quotes
MDMA Pharmala Biotech Holdings Inc
- 0.175
- -0.010-5.41%
15min DelayTrading Feb 27 10:21 ET
16.50MMarket Cap-17.50P/E (TTM)
0.185High0.155Low303.49KVolume0.185Open0.185Pre Close51.21KTurnover0.34052wk High0.32%Turnover Ratio94.29MShares0.06552wk Low-0.01EPS TTM16.50MFloat Cap0.540Historical HighLossP/E (Static)94.29MShs Float0.020Historical Low-0.01EPS LYR16.22%Amplitude--Dividend TTM8.75P/B1Lot Size--Div YieldTTM
Pharmala Biotech Holdings Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | (FY)Aug 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1,768.34%-238.89K | 5.39%-321.36K | -1,655.37%-106.61K | 1,097.14%14.32K | 45.69%-339.66K | -31.52K | 23.50%-313.56K | 131.09%6.85K | 99.47%-1.44K | -260.29%-625.37K |
| Net income from continuing operations | -1,413.46%-479.11K | -5.61%-823.6K | -207.97%-222.57K | 112.64%36.48K | 20.88%-779.81K | ---80.3K | -64.37%-338.74K | 74.67%-72.27K | 4.70%-288.5K | 60.72%-985.58K |
| Operating gains losses | -78.97%35.63K | --157.43K | ---- | --169.43K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 87.23%29.57K | 33.06%70.21K | 19.72%15.78K | 19.84%15.79K | 334.82%52.77K | --13.23K | 2,861.35%13.18K | 2,861.35%13.18K | 5,108.70%13.18K | 3,904.95%12.14K |
| Asset impairment expenditure | ---- | 34.02%22.6K | ---- | ---- | --16.86K | ---- | ---- | ---- | ---- | --0 |
| Remuneration paid in stock | 1,104.98%226.3K | 699.30%541.32K | 228.16%56.59K | -53.92%18.78K | -71.37%67.73K | --5.28K | -69.24%4.45K | -47.80%17.25K | -35.81%40.75K | 65.85%236.53K |
| Other non cashItems | ---- | 245.83%108K | --79.01K | ---54.84K | ---74.06K | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 70.07%-51.27K | -205.43%-397.33K | 175.18%134.01K | -173.49%-171.32K | 237.85%376.86K | --87.47K | 103.45%7.56K | -78.81%48.7K | 809.29%233.14K | 2.33%111.55K |
| -Change in receivables | 345.06%17.31K | 90.94%-10.49K | -147.83%-19.2K | 90.60%-7.06K | -1,382.06%-115.74K | ---138.38K | 289.10%57.6K | 199.24%40.15K | -264.51%-75.12K | 130.63%9.03K |
| -Change in inventory | --0 | -3,855.24%-231.34K | --0 | --112.03K | 94.97%-5.85K | --95.94K | ---101.79K | --0 | --0 | ---116.34K |
| -Change in prepaid assets | -39.94%26.52K | -142.43%-120.68K | -237.96%-320.65K | 14.00%44.16K | 2,086.02%284.42K | ---31.02K | 96.27%44.28K | 399.57%232.43K | 1,229.30%38.74K | ---14.32K |
| -Change in payables and accrued expense | -1,959.31%-169.51K | -116.27%-34.82K | 209.14%144.3K | 977.48%9.12K | -8.21%214.04K | --160.94K | 104.19%7.46K | -86.58%46.68K | 88.24%-1.04K | 68.39%233.18K |
| -Change in other working capital | 122.58%74.41K | ---- | ---- | -221.81%-329.57K | ---- | ---- | ---- | ---- | --270.55K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -1,768.34%-238.89K | 5.39%-321.36K | -1,655.37%-106.61K | 1,097.14%14.32K | 45.69%-339.66K | ---31.52K | 23.50%-313.56K | 131.09%6.85K | 99.47%-1.44K | -260.29%-625.37K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 56.75%-24.44K | 55.32%-226.42K | -69.78%-75.9K | 53.00%-56.51K | 49.07%-506.74K | -269.44K | 69.57%-72.37K | 83.83%-44.7K | -125.00%-120.23K | -258.11%-994.87K |
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -12.07%-2.99K |
| Net intangibles purchas and sale | 56.75%-24.44K | 55.32%-226.42K | -69.78%-75.9K | 53.00%-56.51K | 48.91%-506.74K | ---269.44K | 69.57%-72.37K | 83.83%-44.7K | -138.33%-120.23K | -282.20%-991.88K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 56.75%-24.44K | 55.32%-226.42K | -69.78%-75.9K | 53.00%-56.51K | 49.07%-506.74K | ---269.44K | 69.57%-72.37K | 83.83%-44.7K | -125.00%-120.23K | -258.11%-994.87K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -39.29%42.5K | 307.89%772.12K | 0 | 70K | 189.3K | 0 | 150.2K | 39.1K | 0 | 0 |
| Net common stock issuance | ---- | --697.12K | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | -39.29%42.5K | -60.38%75K | --0 | --70K | --189.3K | --0 | --189.3K | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -39.29%42.5K | 307.89%772.12K | --0 | --70K | --189.3K | --0 | --150.2K | --39.1K | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 115.02%419.38K | -77.11%195.04K | -69.49%222.85K | -77.11%195.04K | -65.53%852.14K | --495.99K | -60.42%731.72K | -65.98%730.47K | -65.53%852.14K | --2.47M |
| Current changes in cash | -894.21%-220.83K | 134.14%224.34K | -14,665.04%-182.5K | 122.85%27.81K | 59.44%-657.1K | ---300.95K | 63.61%-235.73K | 100.42%1.25K | 62.60%-121.67K | -165.53%-1.62M |
| End cash Position | -10.90%198.55K | 115.02%419.38K | -94.49%40.35K | -69.49%222.85K | -77.11%195.04K | --195.04K | -58.70%495.99K | -60.42%731.72K | -65.98%730.47K | -65.53%852.14K |
| Free cash from | -524.08%-263.33K | 35.28%-547.78K | -382.20%-182.5K | 65.32%-42.2K | 47.76%-846.39K | ---300.95K | 40.42%-385.92K | 87.32%-37.85K | 62.60%-121.67K | -271.82%-1.62M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending Stocks
Big Five Big Five
The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.